There are no conversations in this channel.
Please log in to your account to view your subscribed posts.
| Topics | Statistics | Last Post | ||
|---|---|---|---|---|
|
2 responses
540 views
0 reactions
|
by Frank27
07-06-2026, 09:59 PM
|
|||
|
0 responses
53 views
0 reactions
|
06-17-2026, 06:11 AM
|
|||
|
1 response
124 views
0 reactions
|
by HuTasssUn
05-21-2026, 11:38 PM
|
|||
|
0 responses
141 views
0 reactions
|
by isii
01-12-2026, 11:53 AM
|
|||
|
0 responses
219 views
0 reactions
|
by bmseverance
08-25-2025, 09:55 AM
|
|||
|
0 responses
112 views
0 reactions
|
|
|||
|
0 responses
76 views
0 reactions
|
by v_kisand
07-04-2025, 12:26 AM
|
|||
|
1 response
218 views
0 reactions
|
by fchatonnet
06-25-2025, 01:16 AM
|
|||
|
0 responses
174 views
0 reactions
|
by Telemed911
05-03-2025, 02:59 AM
|
|||
|
0 responses
157 views
0 reactions
|
by Oliter_mx
03-24-2025, 09:26 PM
|
No topics found.
-
Next-generation sequencing (NGS) is now central to outbreak investigations and antimicrobial resistance tracking. Through sophisticated...07-31-2026, 07:00 AM
-
The immune system’s power comes from its genetic diversity, allowing myriad threats to be neutralized through first recognizing foreign antigens. That diversity is also what makes the immune system so difficult to study. Recent advances in sequencing technology and computational biology, however, are giving researchers new tools to understand immune responses and immune-related diseases in greater detail.
This convergence of genetics, immunology, and computation...09-01-2026, 05:41 AM -
CRISPR/Cas9 sparked the gene editing revolution for both research and therapeutics.1 But this system still showed severe issues that limited its applications. The most prominent were the heavy reliance on PAM sequences, delivery limitations, double-stranded breaks that prompt unintended edits and cell death, and editing inefficiency (both in targeting and in knock-in reliability).
Despite this, “CRISPR helped turn genome editing from a specialized technique into...07-31-2026, 11:01 AM
